ABBOTT LABORATORIES — Director's Dealing 2021

Sep 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2021-09-03

Reporting Person: WOODGRIFT RANDEL WILLIAM (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-03	Common shares without par value	M	1000	$38.40	Acquired	50093	Direct
2021-09-03	Common shares without par value	S	1000	$129	Disposed	49093	Direct
2021-09-03	Common shares without par value	S	5350	$129	Disposed	43743	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-03	Option (right to buy)	$38.40	M	1000	Disposed	2026-02-18	Common Shares (1000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	3217	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of September 7, 2021.

F2: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.